Distribution of α-Synuclein Aggregation in the Peripheral Tissues

Neurochem Res. 2022 Dec;47(12):3627-3634. doi: 10.1007/s11064-022-03586-0. Epub 2022 Mar 28.

Abstract

Parkinson's disease (PD) is a chronic neurodegenerative disease mainly characterized by movement disorders and other non-motor symptoms, including the loss of dopaminergic neurons in the substantia nigra parts. Abnormal α-synuclein aggregation in the brain is closely associated with the loss of dopaminergic neurons. α-synuclein can propagate in the central nervous system (CNS) and periphery under pathological conditions. Many researches have focused on its aggregation and distribution in the CNS and explored its relationship with PD. But in recent years, the distribution of α-synuclein in peripheral tissues have been paid much attention. This review summarized the distribution of α-synuclein in the choroid plexus, blood, saliva, gastrointestine and other tissues, and discussed the potential mechanism of α-synuclein aggregation, providing a basis for the early diagnosis and intervention of PD.

Keywords: Brain; Parkinson; Peripheral tissues; S disease; α-synuclein aggregation.

Publication types

  • Review

MeSH terms

  • Dopaminergic Neurons / metabolism
  • Humans
  • Neurodegenerative Diseases* / pathology
  • Parkinson Disease* / pathology
  • Substantia Nigra / metabolism
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein